Schedule 13G ownership disclosure

Century Therapeutics, Inc.

Common Stock, par value $0.0001 per share · CUSIP: 15673T100

Event date: 2026-01-09

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • TCG Crossover GP II, LLC

    Shares: 8,877,215 · Class: 4.9%

  • TCG Crossover Fund II, L.P.

    Shares: 8,877,215 · Class: 4.9%

  • TCG Crossover GP III, LLC

    Shares: 8,877,215 · Class: 4.9%

  • TCG Crossover Fund III, L.P.

    Shares: 8,877,215 · Class: 4.9%

  • Chen Yu

    Shares: 17,754,430 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-26-014129
Form type
SCHEDULE 13G
Filer
Century Therapeutics, Inc.
CIK
CIK 1850119
Filed
Jan 15, 2026
Reporting period
Jan 09, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub